BRADLEY G SOMER MD NPI 1851320691

NPI Details

Bradley G Somer, MD is a hematology and oncology internal medicine in Germantown, TN with 30 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Bradley G Somer, MD NPI is 1851320691. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Graduation Year:1996

The provider's business location address is:

7945 WOLF RIVER BLVD
GERMANTOWN, TN
ZIP 38138-762
Phone: (901) 683-0055
Fax: (901) 685-9718

The NPI 1851320691 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, trilaciclib, 1mg (HCPCS:J1448)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, atezolizumab, 10 mg (HCPCS:J9022)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, lanreotide, 1 mg (HCPCS:J1930)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ferritin (blood protein) level (HCPCS:82728)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Blood creatinine level (HCPCS:82565)
• Unclassified drugs (HCPCS:J3490)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Automated urinalysis test (HCPCS:81003)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Red blood count, automated test (HCPCS:85045)
• Nephelometry, test method using light (HCPCS:83883)
• Blood test, clotting time (HCPCS:85610)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Therapy procedure using functional activities (HCPCS:97530)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Folic acid level, serum (HCPCS:82746)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Rheumatoid factor level (HCPCS:86431)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection, mannitol, 25% in 50 ml (HCPCS:J2150)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Training for self-care or home management, each 15 minutes (HCPCS:97535)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Blood glucose (sugar) level (HCPCS:82947)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection of drug or substance into vein (HCPCS:96374)
• Declotting of central venous tube (HCPCS:36593)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)

The enumeration date for this NPI number is 7/2/2006 and was last updated on 2/7/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.